The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Heparanase as mediator of angiogenesis: mode of action
Abstract
Extracellular matrix (ECM) and basement membranes (BMs) present a physical barrier that requires enzymatic degradation during endothelial cell (EC) sprouting at early stages of angiogenesis. These multimolecular structures also serve as a storage depot for heparin‐binding angiogenic factors. Heparan sulfate proteoglycans (HSPGs) are responsible for the self‐assembly and integrity of the ECM and BM structure, as well as for sequestration of growth and differentiation factors. Recently, we reported the cloning of heparanase, an endo‐β‐ d ‐glucuronidase degrading heparan sulfate (HS), and provided direct evidence for its role in tumor metastasis. We now demonstrate that heparanase is intimately involved in angiogenesis and elucidate its mode of action. Apart from its direct involvement in ECM degradation and EC migration (vascular sprouting), heparanase releases active basic fibroblast growth factor (bFGF) from the subendothelial ECM, as well as bFGF‐stimulating HS degradation fragments from the EC surface. Interestingly, ECM‐derived HS fragments induced little or no potentiation of the growth‐promoting activity of bFGF. The angiogenic effect of heparanase was demonstrated in vivo (via the Matrigel plug assay) by showing a three‐ to fourfold increase in neovascularization induced by murine T‐lymphoma cells after stable transfection with the heparanase gene. Increased tissue vascularity was also observed in a mouse wound‐healing model in response to topical administration of recombinant heparanase. Immunohistochemical staining of human colon carcinoma tissue revealed a high expression of the heparanase protein in the endothelium of sprouting capillaries and small vessels, but not of mature quiescent blood vessels. The ability of heparanase to promote tumor angiogenesis and its involvement in tumor metastasis make it a promising target for cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Functions of Cell Surface Heparan Sulfate Proteoglycans
Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., & Zako, M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.729 · Cited by 2,688
Blood Vessel Formation: What Is Its Molecular Basis?
Folkman, J., & D'Amore, P. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81810-3 · Cited by 1,215
Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention
Stetler-Stevenson, W. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6870 · Cited by 842
Passaniti, A., Taylor, R. M., Пили, Р., Guo, Y., Long, P., Haney, J. A., Pauly, R. R., Grant, D. S., & Martin, G. R. (1992) · PubMed · Cited by 806
Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
Vlodavsky, I., Friedmann, Y., Elkin, M., Aingorn, H., Atzmon, R., Ishai-Michaeli, R., Bitan, M., Pappo, O., Peretz, T., Michal, I., et al. (1999) · Nature Medicine · doi:10.1038/10518 · Cited by 803
Self-citationVukicevic, S., Kleinman, H. K., Luyten, F. P., Roberts, A. B., Roche, N. S., & Reddi, A. H. (1992) · Experimental Cell Research · doi:10.1016/0014-4827(92)90397-q · Cited by 696
Spivak-Kroizman, T., Lemmon, M. A., Dikic, I., Ladbury, J. E., Pinchasi, D., Huang, J., Jaye, M., Crumley, G., Schlessinger, J., & Lax, I. (1994) · Cell · doi:10.1016/0092-8674(94)90032-9 · Cited by 658
Iozzo, R. V., & Murdoch, A. D. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.5.8621059 · Cited by 642
Ornitz, D. M., Yayon, A., Flanagan, J. G., Svahn, C. M., Levi, E., & Leder, P. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.240 · Cited by 632
Aviezer, D., Hecht, D., Safran, M., Eisinger, M., David, G., & Yayon, A. (1994) · Cell · doi:10.1016/0092-8674(94)90031-0 · Cited by 536
Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis
Hulett, M. D., Freeman, C., Hamdorf, B. J., Baker, R. T., Harris, M. J., & Parish, C. R. (1999) · Nature Medicine · doi:10.1038/10525 · Cited by 518
Parish, C. R., Freeman, C. G., Brown, K. J., Francis, D. J., & Cowden, W. B. (1999) · PubMed · Cited by 445
Current Protocols in Cell Biology
(2018) · Current Protocols in Cell Biology · doi:10.1002/(issn)1934-2616 · Cited by 357
Heparanases and tumor metastasis
Nakajima, M., Irimura, T., & Nicolson, G. L. (1988) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240360207 · Cited by 305
Toyoshima, M., & Nakajima, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24153 · Cited by 297
Vlodavsky, I., Miao, H.-Q., Medalion, B., Danagher, P., & Ron, D. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437470 · Cited by 286
Self-citationExpression of Heparanase in Normal, Dysplastic, and Neoplastic Human Colonic Mucosa and Stroma
Friedmann, Y., Vlodavsky, I., Aingorn, H., Aviv, A., Peretz, T., Pecker, I., & Pappo, O. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64632-9 · Cited by 202
Self-citationProcessing of the Human Heparanase Precursor and Evidence That the Active Enzyme Is a Heterodimer
Fairbanks, M. B., Mildner, A. M., Leone, J. W., Cavey, G. S., Mathews, W. R., Drong, R. F., Slightom, J. L., Bienkowski, M. J., Smith, C. W., Bannow, C. A., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.29587 · Cited by 198
Sloane, B. F., Moin, K., Sameni, M., Tait, L. R., Rozhin, J., & Ziegler, G. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.2.373 · Cited by 185
Schweitzer, K., Vicart, P., Delouis, C., Paulin, D., Dräger, A. M., Langenhuijsen, M. M. A. C., & Weksler, B. B. (1997) · PubMed · Cited by 176
Heparanase, a potential regulator of cell–matrix interactions
Dempsey, L. A., Brunn, G. J., & Platt, J. L. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01619-4 · Cited by 173
Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
Vlodavsky, I., Mohsen, M., Lider, O., Cm, S., Hp, E., Vigoda, M., Ishai-Michaeli, R., & Peretz, T. (1994) · PubMed · Cited by 170
Self-citationParish, C. R., Coombe, D. R., Jakobsen, K. B., Bennett, F. A., & Underwood, P. A. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910400414 · Cited by 158
PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated β-catenin
Ilan, N., Mahooti, S., Rimm, D. L., & Madri, J. A. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.18.3005 · Cited by 147
Self-citationChang, Z., Meyer, K., Rapraeger, A., & Friedl, A. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.1.137 · Cited by 119
Gilat, D., Hershkoviz, R., Goldkorn, I., Cahalon, L., Korner, G., Vlodavsky, I., & Lider, O. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.5.1929 · Cited by 118
Self-citationIshai-Michaeli, R., Svahn, C. M., Weber, M., Chajek-Shaul, T., Korner, G., Ekre, H. P., & Vlodavsky, I. (1992) · Biochemistry · doi:10.1021/bi00122a027 · Cited by 87
Self-citationVlodavsky, I. (1999) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb1004s01 · Cited by 86
Self-citationMiao, H., Ornitz, D. M., Aĭngorn, E. D., Ben‐Sasson, S. A., & Vlodavsky, I. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119319 · Cited by 82
Self-citationEndothelial Cell Heparanase Modulation of Lipoprotein Lipase Activity
Pillarisetti, S., Paka, L., Sasaki, A., Vanni, T. M., Yin, B., Parthasarathy, N., Wagner, W. D., & Goldberg, I. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.15753 · Cited by 80
Extracellular Matrix-Bound Growth Factors, Enzymes, and Plasma Proteins
Vlodavsky, I., Bar‐Shavit, R., Korner, G., & FUKS, Z. Y. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-593165-6.50022-x · Cited by 64
Self-citation
Cited by
Klaassen, I., Van Noorden, C. J. F., & Schlingemann, R. O. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.02.001 · Cited by 722
Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis
Vlodavsky, I., & Friedmann, Y. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13662 · Cited by 618
Self-citationInterstitial Flow and Its Effects in Soft Tissues
Swartz, M. A., & Fleury, M. E. (2007) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.9.060906.151850 · Cited by 598
Axis of evil: molecular mechanisms of cancer metastasis
Bogenrieder, T., & Herlyn, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206757 · Cited by 593
Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis
Ilan, N., Elkin, M., & Vlodavsky, I. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.06.004 · Cited by 524
Self-citation
Metadata
- Authors
- Elkin, M., Ilan, N., Ishai-Michaeli, R., Friedmann, Y., Papo, O., Pecker, I., & Vlodavsky, I.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-05-29
- Volume
- 15
- Issue
- 9
- Pages
- 1661-1663
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2156764890
- Cited by
- 310
- References
- 32
- FWCI
- 5.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.